Citizens Reiterates Market Outperform on BeOne Medicines, Maintains $396 Price Target
شركة بيجين المحدودة
BeiGene Ltd ADR ONC | 0.00 |
Citizens analyst Reni J. Benjamin reiterates BeOne Medicines (NASDAQ:
ONC) with a Market Outperform and maintains $396 price target.
